Latest Articles

The Logistics of Multigene Panel Testing in Breast Cancer
BY MEERI KIM

Generally, health insurance covers the cost of genetic testing recommended by a physician. However, some patients who had BRCA testing in the past have had trouble getting reimbursed for a follow-up panel test. The outof- pocket cost for a single panel test can be up to $5,000, although lower-cost tests are available.
Young Patients With Cancer Don't Always Get the Info They Need
BY MARILYN FENICHEL
When treated for cancer, young patients don’t always get the information they need from doctors.
Exploring Genetic Differences in Men's Breast Cancer
BY MEIR RINDE
The genetic differences that distinguish men’s breast cancers may lead to new diagnosis and treatment options.
Social Disparities Affect Cancer Treatment and Outcomes
BY MARILYN FENICHEL
Socioeconomic status, race and other disparities among patients can affect cancer treatments and outcomes. Researchers are working to change that.
CAR T-Cell Therapy Yescarta Approved to Treat Non-Hodgkin Lymphoma
BY BETH INCOLLINGO
Yescarta was granted FDA approval for use in adults with relapsed or refractory non-Hodgkin lymphoma. This is only the second CAR T-cell therapy ever approved.
Care to Comment on Draft USPSTF Statement on Sun Protection?
BY MINDY WAIZER
Members of the public can submit comments to the U.S. Preventive Services Task Force (USPSTF) on its draft recommendation statement on sun protection until Nov. 6, 2017.
Opdivo Granted Priority Review for Post-Surgical Melanoma Treatment
BY JASON HARRIS
Opdivo (nivolumab) was granted a priority review to a supplemental biologics license application (sBLA) to treat patients with melanoma who have a high risk of disease recurrence after complete surgical resection, according to Bristol-Myers Squibb (BMS), the company that makes the drug.
 
Piling on Drugs to Treat HER2-Positive Breast Cancer
BY GINA BATTAGLIA, PH.D.
More and more, treating HER2-positive breast cancers involves combining an array of drugs.
Do Genes and Gender Play a Role in Chemotherapy-Related Fatigue?
BY BRIELLE URCIUOLI
Genetics may play a role in chemotherapy-related fatigue, according to a recent study.
x
//For side ad protocol